Metraipolis › archive › dc_4359dc049e90

Material Basis and Mechanisms of Action of PuRenDan in the Treatment of Type 2 Diabetes Mellitus: An Integrated Network Pharmacology and Molecular Simulation… — Europe PMC PMID:42515787

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42515787
DOI
10.3390/ph19071107
License (as archived)
solo-consultazione
Archived
2026-10-08T01:14:33.318Z
SHA-256 of the archived text
9e1294e91558d1e8d55b05e48a459b36118bc40a89c9923a5b9a6233e7a80195
Stable URL of this page
https://metraipolis.com/documento/dc_4359dc049e90

How to cite

Material Basis and Mechanisms of Action of PuRenDan in the Treatment of Type 2 Diabetes Mellitus: An Integrated Network Pharmacology and Molecular Simulation… — Europe PMC PMID:42515787 — Europe PMC (en), https://europepmc.org/article/MED/42515787 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4359dc049e90 (Metraipolis archive dc_4359dc049e90, sha256 9e1294e91558d1e8d55b05e48a459b36118bc40a89c9923a5b9a6233e7a80195)
BibTeX
@misc{dc4359dc049e90,
  title = {Material Basis and Mechanisms of Action of PuRenDan in the Treatment of Type 2 Diabetes Mellitus: An Integrated Network Pharmacology and Molecular Simulation… — Europe PMC PMID:42515787},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42515787},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4359dc049e90; sha256 9e1294e91558d1e8d55b05e48a459b36118bc40a89c9923a5b9a6233e7a80195},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42515787. Agents can read the archived copy with the MCP tool read_document.